PepGen, Inc. (NASDAQ:PEPG) Given Consensus Recommendation of “Moderate Buy” by Analysts
Shares of PepGen, Inc. (NASDAQ:PEPG – Get Free Report) have been given a consensus rating of “Moderate Buy” by the seven research firms that are currently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating and six have assigned a buy rating to the company. The average […]
Ecolab Inc. (NYSE:ECL) Receives Average Recommendation of “Moderate Buy” from Analysts
Ecolab Inc. (NYSE:ECL – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the twenty-one ratings firms that are presently covering the company, MarketBeat reports. Three investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to […]
LGI Homes, Inc. (NASDAQ:LGIH) Given Consensus Recommendation of “Hold” by Brokerages
LGI Homes, Inc. (NASDAQ:LGIH – Get Free Report) has received an average recommendation of “Hold” from the six analysts that are presently covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a sell recommendation, two have issued a hold recommendation and two have issued a buy recommendation on the company. The […]
Immunome, Inc. (NASDAQ:IMNM) Given Average Recommendation of “Moderate Buy” by Analysts
Immunome, Inc. (NASDAQ:IMNM – Get Free Report) has earned an average recommendation of “Moderate Buy” from the thirteen ratings firms that are presently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating and twelve have assigned a buy rating to the company. The average 12 month price […]
Guidewire Software, Inc. (NYSE:GWRE) Receives Consensus Recommendation of “Moderate Buy” from Brokerages
Guidewire Software, Inc. (NYSE:GWRE – Get Free Report) has been given an average recommendation of “Moderate Buy” by the thirteen brokerages that are presently covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The average 1 year target […]
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Receives Average Recommendation of “Moderate Buy” from Brokerages
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twelve research firms that are presently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, one has given a hold recommendation, nine have assigned a buy recommendation […]
last updated on 4 Jul 10:26